The Latest Advances in Cervical Cancer Screening and Management:
Performance and Genotyping Results from the BD Onclarity™ HPV Assay US Clinical Trial
What are the latest advances in HPV and cervical cancer screening that could improve outcomes for your patients? Find out when you join noted experts Mark H. Stoler, MD, and Thomas C. Wright, Jr., MD, at ASCCP 2018. They will review the data and results from the BD Onclarity™ US clinical trial - a prospective, multi-center clinical trial that included more than 33,500 US women. The presentations will cover performance by intended use, including ASCUS triage, co-testing, primary screening, and results in vaccinated and unvaccinated cohorts. Discover how this new HPV diagnostic test will provide clinicians with another choice in detecting and genotyping high-risk HPV virus infection.
DISCUSSION WILL COVER: